TY - JOUR T1 - Protective Effect of Chronic Vitamin C Treatment on Endothelial Function of Apolipoprotein E-Deficient Mouse Carotid Artery JF - Journal of Pharmacology and Experimental Therapeutics JO - J Pharmacol Exp Ther SP - 103 LP - 108 DO - 10.1124/jpet.103.049163 VL - 306 IS - 1 AU - Takuya Matsumoto AU - Livius V. d'uscio AU - Daihiko Eguchi AU - Masahiko Akiyama AU - Leslie A. Smith AU - Zvonimir S. Katusic Y1 - 2003/07/01 UR - http://jpet.aspetjournals.org/content/306/1/103.abstract N2 - Endothelium-dependent relaxations are impaired in carotid artery of apolipoprotein E-deficient (apoE–/–) mice. This impairment seems to be due to increased formation of superoxide anions and inactivation of endothelial nitric oxide (NO). In the present study, we tested hypothesis that chronic treatment with vitamin C may prevent endothelial dysfunction by increasing release of NO from endothelial cells. C57BL/6 and apoE–/– mice were treated for 26 weeks with Western-type fat diet with and without 1% vitamin C. Vasomotor function of isolated carotid arteries was studied by video dimension analyzer. Expression of endothelial NO synthase (eNOS) and platelet-endothelial cell adhesion molecule-1 (PECAM-1) protein were evaluated by Western blotting. Levels of cGMP and cAMP were measured by radioimmunoassay. In apoE–/– mice, vitamin C significantly augmented relaxations to acetylcholine (10–9–10–5 mol/l), but did not affect relaxations to NO donor diethylammonium-(Z)-1-(N,N-diethylamino) diazen-1-1,2-diolate (DEA-NONOate; 10–9–10–5 mol/l). In contrast, vitamin C reduced relaxations to acetylcholine and DEA-NONOate in C57BL/6 mice. Interestingly, vitamin C significantly increased basal cGMP levels in C57BL/6 mice but did not affect cGMP formation in apoE–/–. Vitamin C treatment did not affect expression of eNOS protein, whereas elevated expression of PECAM-1 protein in apoE–/– mice was returned to normal level. Our findings demonstrate that chronic treatment with vitamin C prevents endothelial dysfunction of carotid artery induced by hypercholesterolemia. This effect seems to be mediated by preservation of NO bioavailability in endothelial cells. The American Society for Pharmacology and Experimental Therapeutics ER -